Records containing: Nonalcoholic Fatty Liver Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-02-26Investigation of Effectiveness of Different Exercise Types, and Their Therapeutic Effect Mechanisms and the Roles of Motivational Interview in the Treatment of Non-Alcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2023-12-12Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2023-11-15Effects of Time-Restricted Feeding on Nonalcoholic Fatty Liver Disease in Obese Adults: a Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2023-11-15A Phase 2a, Randomized, Active-Comparator-Controlled, Open-Label Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Individuals With Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2023-10-05Non-Alcoholic Fatty Liver Disease in a Saudi Cohort With Type 2 Diabetes Mellitus
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-09-21A Phase 1B, Repeated Dose Study, to Evaluate the Safety, PD and PK Profile of CM-101 in NAFLD Patients With Normal Liver Function Tests and Stable NAFLD/NASH Patients With NAFLD Activity Score (NAS) < 3-The SPARK Study
-
CLINICAL_TRIALS study record update · 2023-08-14The University of Michigan Wellness Education for Liver Health Study
-
CLINICAL_TRIALS study record update · 2023-04-13A PHASE 2A, 2-PART, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY PLACEBO-CONTROLLED, PARALLEL-GROUP (SPONSOR OPEN) STUDY TO ASSESS PHARMACODYNAMICS AND SAFETY OF PF-06865571 (DGAT2I) COADMINISTERED WITH PF-05221304 (ACCI) IN ADULT PARTICIPANTS WITH PRESUMED NONALCOHOLIC STEATOHEPATITIS (NASH)
-
CLINICAL_TRIALS study record update · 2022-11-30Study on the Characteristic, Therapy and Prognosis of Patients With Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2022-10-17Effect of N-acetyl Cysteine on Non Alcoholic Fatty Liver Disease in Obese Children
-
CLINICAL_TRIALS study record update · 2022-09-22The Effect of Weight Gain After Smoking Cessation Increased the Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2022-08-31Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD
-
CLINICAL_TRIALS study record update · 2022-07-01A Randomized Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of FM101 in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis
-
CLINICAL_TRIALS study record update · 2022-06-09A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 1b Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2022-04-19The Development of Preventive Methods for Chronic Noncommunicable Diseases Based on Modulation of Gut Microbiota Composition and Function
-
CLINICAL_TRIALS study record update · 2022-04-06Effects of Time-Restricted Feeding on Nonalcoholic Fatty Liver Disease in Obese Adults: a 12-month Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2022-03-25Comparison of Dietary Sugar Reduction Methods
-
CLINICAL_TRIALS study record update · 2021-12-29A Proof-of-Concept and Dose-Ranging Study Investigating the Efficacy and Safety of HTD1801 in Adults With NASH and T2DM
-
CLINICAL_TRIALS study record update · 2021-11-02A Parallel Cohort Controlled Trial of Outcome of Nonalcoholic Steatohepatitis in Adolescents After Bariatric Surgery vs. Comprehensive Lifestyle Intervention (NASH ABC)
-
CLINICAL_TRIALS study record update · 2021-08-03Pilot Study: Diabetes Prevention Program for the Treatment of Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2021-07-09A Randomized, Prospective, Open Label, Active Control, Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2021-05-11A Phase 1a/1b Study of Safety, Tolerability, and Pharmacokinetics of CB4211 in Healthy Non-obese Subjects and Subjects With Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2021-04-15The Effect of Mediterranean Diet and Low Fat Diet on Hepatic Fat, Inflammation and Oxidative Stress in Obese Adolescents With Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2021-02-26Effects of Febuxostat for Interventions of Lowering Uric Acid in Patients With Gout With Nonalcoholic Fatty Liver Disease: a Multicenter, Open-label, Randomized, Controlled Study
-
CLINICAL_TRIALS study record update · 2020-09-04RiFL: Rifaximin in Fatty Liver Disease. Does Modulation of Gut Microbiota Reduce Hepatic Inflammation in Non-Alcoholic Steatohepatitis (NASH)?